Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner
Butyrate is a typical short chain fatty acid produced by gut microbiota of which the dysmetabolism has been consistently associated with colorectal diseases. However, whether butyrate affects metastatic colorectal cancer is not clear. In this study we investigated in vitro the effect of butyrate on...
Saved in:
Main Authors: | Qingran Li (Author), Chujie Ding (Author), Tuo Meng (Author), Wenjie Lu (Author), Wenyue Liu (Author), Haiping Hao (Author), Lijuan Cao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
by: Ana Vuletić, et al.
Published: (2023) -
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors
by: Yiming Chen, et al.
Published: (2021) -
Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020) -
Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
by: Palak Gujral, et al.
Published: (2020) -
Clinical Toxicities of Histone Deacetylase Inhibitors
by: Richard L. Piekarz, et al.
Published: (2010)